Patents by Inventor Christine Thioudellet

Christine Thioudellet has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Oncolytic virus for expression of immune checkpoint modulators
    Patent number: 11779619
    Abstract: The present invention provides an oncolytic virus comprising nucleotide sequence(s) encoding one or more immune checkpoint modulator(s). It also concerns a pharmaceutical composition comprising effective amount of said oncolytic virus and, eventually, a pharmaceutically acceptable vehicle and its use for treating proliferative diseases such as cancers.
    Type: Grant
    Filed: December 23, 2019
    Date of Patent: October 10, 2023
    Assignee: Transgene SA
    Inventors: Nathalie Silvestre, Michel Geist, Karola Rittner, Jean-Baptiste Marchand, Christine Thioudellet
  • Parapoxvirus vectors
    Publication number: 20210000937
    Abstract: The present invention is in the field of viral immunotherapy. The invention provides new pseudocowpox (PCPV) viruses, in particular recombinant PCPV, composition thereof as well as their therapeutic use for preventing or treating diseases, and, notably, proliferative diseases like cancers and restenosis and infectious diseases such as chronic ones. The present invention also provides methods for generating and amplifying such a PCPV and a method for eliciting or stimulating and/or re-orienting an immune response using such a PCPV. More specifically, the invention provides an alternative to the existing poxvirus vectors such as MVA (Modified Virus Ankara) and may be largely used for the therapeutic vaccination.
    Type: Application
    Filed: March 17, 2019
    Publication date: January 7, 2021
    Applicant: TRANSGENE
    Inventors: Karola RITTNER, Christelle REMY, Christine THIOUDELLET
  • ONCOLYTIC VIRUS FOR EXPRESSION OF IMMUNE CHECKPOINT MODULATORS
    Publication number: 20200197457
    Abstract: The present invention provides an oncolytic virus comprising nucleotide sequence(s) encoding one or more immune checkpoint modulator(s). It also concerns a pharmaceutical composition comprising effective amount of said oncolytic virus and, eventually, a pharmaceutically acceptable vehicle and its use for treating proliferative diseases such as cancers.
    Type: Application
    Filed: December 23, 2019
    Publication date: June 25, 2020
    Applicant: Transgene S.A.
    Inventors: Nathalie Silvestre, Michel Geist, Karola Rittner, Jean-Baptiste Marchand, Christine Thioudellet
  • Oncolytic virus for expression of immune checkpoint modulators
    Patent number: 10555981
    Abstract: The present invention provides an oncolytic virus comprising nucleotide sequence(s) encoding one or more immune checkpoint modulator(s). It also concerns a pharmaceutical composition comprising effective amount of said oncolytic virus and, eventually, a pharmaceutically acceptable vehicle and its use for treating proliferative diseases such as cancers.
    Type: Grant
    Filed: July 16, 2015
    Date of Patent: February 11, 2020
    Assignee: Transgene S.A.
    Inventors: Nathalie Silvestre, Michel Geist, Karola Rittner, Jean-Baptiste Marchand, Christine Thioudellet
  • Antibody against the CSF-1R
    Patent number: 9982055
    Abstract: The present invention provides antibodies specific for the CSF-1R, compositions comprising said antibodies and methods of treatment using such compositions.
    Type: Grant
    Filed: July 19, 2016
    Date of Patent: May 29, 2018
    Assignee: TRANSGENE S.A.
    Inventors: Hélène Haegel, Christine Thioudellet, Michel Geist, Benoit Grellier, Jean-Baptiste Marchand
  • ONCOLYTIC VIRUS FOR EXPRESSION OF IMMUNE CHECKPOINT MODULATORS
    Publication number: 20170157188
    Abstract: The present invention provides an oncolytic virus comprising nucleotide sequence(s) encoding one or more immune checkpoint modulator(s). It also concerns a pharmaceutical composition comprising effective amount of said oncolytic virus and, eventually, a pharmaceutically acceptable vehicle and its use for treating proliferative diseases such as cancers.
    Type: Application
    Filed: July 16, 2015
    Publication date: June 8, 2017
    Applicant: Transgene S.A.
    Inventors: Nathalie Silvestre, Michel Geist, Karola Rittner, Jean-Baptiste Marchand, Christine Thioudellet
  • ANTIBODY AGAINST THE CSF-1R
    Publication number: 20170002081
    Abstract: The present invention provides antibodies specific for the CSF-1R, compositions comprising said antibodies and methods of treatment using such compositions.
    Type: Application
    Filed: July 19, 2016
    Publication date: January 5, 2017
    Inventors: Hélène HAEGEL, Christine Thioudellet, Michel Geist, Benoit Grellier, Jean-Baptiste Marchand
  • Antibody against the CSF-1R
    Patent number: 9428584
    Abstract: The present invention provides antibodies specific for the CSF-1R, compositions comprising said antibodies and methods of treatment using such compositions.
    Type: Grant
    Filed: May 17, 2013
    Date of Patent: August 30, 2016
    Assignee: Transgene S.A.
    Inventors: Hèléne Haegel, Christine Thioudellet, Michel Geist, Benoît Grellier, Jean-Baptiste Marchand
  • Antibody against the CSF-1R
    Patent number: 9221912
    Abstract: The present invention provides antibodies specific for the CSF-1R, compositions comprising said antibodies and methods of treatment using such compositions.
    Type: Grant
    Filed: July 1, 2013
    Date of Patent: December 29, 2015
    Assignee: Transgene S.A.
    Inventors: Hélène Haegel, Christine Thioudellet, Michel Geist, Benoît Grellier
  • ANTIBODY AGAINST THE CSF-1R
    Publication number: 20140057972
    Abstract: The present invention provides antibodies specific for the CSF-1R, compositions comprising said antibodies and methods of treatment using such compositions.
    Type: Application
    Filed: July 1, 2013
    Publication date: February 27, 2014
    Applicant: TRANSGENE S.A.
    Inventors: Hélène HAEGEL, Christine THIOUDELLET, Michel GEIST, Benoît GRELLIER
  • Antibody against the CSF-1R
    Patent number: 8604170
    Abstract: The present invention provides antibodies specific for the CSF-1R, compositions comprising said antibodies and methods of treatment using such compositions.
    Type: Grant
    Filed: March 11, 2009
    Date of Patent: December 10, 2013
    Assignee: Transgene S.A.
    Inventors: Hélène Haegel, Christine Thioudellet, Michel Geist, Benoît Grellier
  • ANTIBODY AGAINST THE CFR-1R
    Publication number: 20130289250
    Abstract: The present invention provides antibodies specific for the CSF-1R, compositions comprising said antibodies and methods of treatment using such compositions.
    Type: Application
    Filed: May 17, 2013
    Publication date: October 31, 2013
    Applicant: TRANSGENE, S.A.
    Inventors: Helene HAEGEL, Christine THIOUDELLET, Michel GEIST, Benoit GRELLIER, Jean-Baptiste MARCHAND
  • Antibody against the CSF-1R
    Patent number: 8470977
    Abstract: The present invention provides antibodies specific for the CSF-1R, compositions comprising said antibodies and methods of treatment using such compositions.
    Type: Grant
    Filed: February 14, 2011
    Date of Patent: June 25, 2013
    Assignee: Transgene S.A.
    Inventors: Hélène Haegel, Christine Thioudellet, Michel Geist, Benoît Grellier, Jean-Baptiste Marchand
  • Antibody Against the CSF-1R
    Publication number: 20110178278
    Abstract: The present invention provides antibodies specific for the CSF-1R, compositions comprising said antibodies and methods of treatment using such compositions.
    Type: Application
    Filed: February 14, 2011
    Publication date: July 21, 2011
    Inventors: Hélène HAEGEL, Christine Thioudellet, Michel Geist, Benoît Grellier, Jean-Baptiste Marchand
  • ANTIBODY AGAINST THE CSF-1 R
    Publication number: 20110081353
    Abstract: The present invention provides antibodies specific for the CSF-1R, compositions comprising said antibodies and methods of treatment using such compositions.
    Type: Application
    Filed: March 11, 2009
    Publication date: April 7, 2011
    Inventors: Hélène Haegel, Christine Thioudellet, Michel Geist, Benoît Grellier